Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Autor: Harmony Outcomes committees and investigators, Hernandez, Adrian F.1, Green, Jennifer B.1, Granger, Christopher B.1, Rosenberg, Anne E.1, Sigmon, Kristina N.1, Janmohamed, Salim2, Jones, Nigel P.2, Thorpe, Karl M.2, D'Agostino Sr., Ralph B.3, Leiter, Lawrence A.4, Somerville, Matthew C.5, McMurray, John J. V.6, Del Prato, Stefano7, D'Agostino, Ralph B Sr8
Zdroj: Lancet. 10/27/2018, Vol. 392 Issue 10157, p1519-1529. 11p.
Databáze: Academic Search Ultimate